BioSpace News Archive

Business

Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin

Cidara Therapeutics, Inc. and Mundipharma announced that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of invasive fungal infections.

September 3, 2019
·
8 min read
Deals

Immunic, Inc. to Participate in Scientific and Investor Conferences in September 2019

Immunic, Inc. announced management’s participation in the following scientific and investor conferences in September

September 3, 2019
·
4 min read
Genetown

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology

September 3, 2019
·
7 min read
Global Strain Gauges Market 2019-2023 | Large Number of Applications of Strain Gauges in Industries to Boost Growth | Technavio

The global strain gauges market size is poised to reach USD 67.93 million by 2023, according to a new report by Technavio, progressing at a CAGR of 5% during the forecast period.

September 3, 2019
·
4 min read
Deals

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2019

Zimmer Biomet Holdings, Inc. announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2019.

September 3, 2019
·
1 min read
Drug Development

BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

BioLineRx Ltd. announced that it has successfully completed the dose-escalation part of the Phase 1/2a clinical study for AGI-134, a novel compound that evokes a direct anti-tumor response, as well as a vaccine effect, via a unique, multi-arm mechanism that targets patient-specific tumor neoantigens.

September 3, 2019
·
6 min read
Deals

Intec Pharma to Participate in September Investment Conferences

Intec Pharma Ltd. announces that Company management will participate at the following upcoming investment conferences in September.

September 3, 2019
·
4 min read
BioCapital

CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference

CASI Pharmaceuticals, Inc. announces it will present at the 2019 H.C. Wainwright 21st Annual Global Investment Conference being held September 8-10, 2019 in New York, NY.

September 3, 2019
·
4 min read
Pharm Country

Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference - Sept. 3, 2019

Bristol-Myers Squibb Company will take part in a fireside chat at the Morgan Stanley Conference on Monday, September 9, 2019, in New York.

September 3, 2019
·
1 min read
FDA

Allergan Receives FDA Approval of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula

Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA® XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE™ cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21.

September 3, 2019
·
8 min read